ѻý

<ѻý class="page-title">Meeting Coverage

DDW Expert Roundtable

<ѻý class="page-description">Expert Roundtable from Digestive Disease Week
Intestinal Ultrasound Predicts Endoscopic Healing by Week 14

Our expert roundtable discusses the role of intestinal ultrasound in early therapy optimization

image
<ѻý class="section_title">Latest DDW Expert Roundtable Meeting Coverage
High-Dose Upadacitinib Appears Safe, Effective in Acute Severe IBD

Our expert roundtable looks at a case series involving UC and Crohn's disease inpatients

June 16, 2023
Risankizumab Safe in Older Crohn's Disease Patients

Our expert roundtable discusses the findings of a post-hoc analysis presented at DDW

June 9, 2023
Reaction to FDA's Approval of Upadacitinib for Crohn's Disease

Our expert roundtable dives into the JAK inhibitor's new indication

June 2, 2023
Risankizumab Safe, Effective in Moderate to Severe Crohn's Disease

Our expert panel discusses the positive data from the phase III ADVANCE and MOTIVATE studies

July 6, 2021
'How Long Do I Need to Stay on Crohn's Therapy?'

Our panel discusses a trial on infliximab discontinuation in patients in remission

June 28, 2021
Biologic Therapies for Crohn's Go Head-to-Head at DDW

SEAVUE compares ustekinumab with adalimumab in patients with moderate to severe disease

June 21, 2021
Do COVID-19 Vaccines Protect IBD Patients?

CLARITY IBD findings weren't clear for IBD patients on infliximab, these experts noted

June 14, 2021